Interestingly enough, YBX1 has been reported as a prognostic marker for poor outcome and chemotherapy efficacy in colorectal cancer, breast cancer, nasopharyngeal carcinoma, and many other cancers.43, 44, 45. Here, YBX1 is linked to breast cancer.